Chronic Kidney Disease

EDITORIAL: CABG or PCI: which is better for revascularization of coronary artery disease in chronic kidney disease?

Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease

Webinar: Registro de Enfermedad Renal Crónica (ERC) etapa 4 e inicio de diálisis programado

慢性肾脏病、透析和肾移植人群中的抗丙型肝炎病毒新疗法

New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant

Challenges and opportunities for stem cell therapy in patients with chronic kidney disease

Precision medicine comes of age in nephrology: identification of novel biomarkers and therapeutic targets for chronic kidney disease

PEER: Insights for Improving Care in Kidney Disease Patients

Mineralocorticoid receptor antagonists in ESRD: Efficacy and Safety

Geriatric CKD and ESRD

CKD in Children

CKD – A Person’s Life-Long Journey with Dialysis

Blocage du système Rénine-Angiotensine-Aldostérone dans la maladie rénale: quelles preuves avec le Périndopril chez le patient hypertendu diabétique?

Prévention des complications de la maladie rénale chronique: Place de la trithérapie à base de Périndopril

Epidémiologie de la maladie rénale chronique de l’adulte en Afrique

Cardio-Vascular Risk in CKD

Etiology and Management of CKD-MBD

Le syndrome cardio-rénal

ISN – KDIGO: Webinar Series: Nephropathic cystinosis

Proton pump inhibitors and chronic kidney disease: is it time to sound the alarm?

Webinar: HTA et maladie rénale chronique – cause et conséquence, dépistage et prise en charge, traitement

Webinar: Mesoamerican Nephropathy

Sclerostin levels in CKD patients: an important, but not definitive, step on the way to clinical use (COMMENTARY)

Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification

Diverse diuretics regimens differentially enhance the antialbuminuric effect of renin–angiotensin blockers in patients with chronic kidney disease

Preventing CKD progression and the case of kidney self repair

Effectiveness of integrated care on delaying CKD progression in rural communities of Thailand (ESCORT STUDY)

Instilling patient autonomy can have an influence on outcome in CKD

Pregnancy in CKD: optimization strategies, diets and beyond

Oxaluria

Chronic dialysis program in African countries: Barriers and successes

Epidemiology, disease patterns and the rise of CKD around the world

Early detection of CKD in low income countries: To screen or not to screen (Con)

Do we need to develop registries for CKD patients in early stages of CKD?

Pregnancy risks in advanced CKD and ethnicity: In whom should we have second thoughts?

Brain damage in ESRD patients

Dent’s disease

CKD in China: treatment deployment and harmonization

Social and environmental threats to general and kidney health in South America

Early detection of CKD in low income countries: To screen or not to screen (pro)

Cystinosis

The vulnerable myocardium in CKD

Incidence of obstetrical thrombotic thrombocytopaenic purport in a retrospective study within thrombocytopaenic pregnant women: a difficult diagnosis and a treatable disease

CKD-Y: Next Generation sequencing reclassifies primary disease diagnoses in young CKD/ESRD patients

Early stage kidney disease and sudden death in the regards cohort study

End-stage kidney disease and the risk of stroke: a cohort study of 10,745 people

THE FINANCIAL COSTS INCURRED TO FAMILIES OF CHILDREN ON LONG TERM RENAL REPLACEMENT THERAPY AT A TERTIARY HEALTH CENTRE IN JOHANNESBURG, SOUTH AFRICA

What have we learned on prevention of progression?

Cost-Effectiveness of Renal Outcome Modification by Educational Intervention for Moderate-stage Chronic Kidney Disease in Japan

Webinar: Challenges to improve CKD care in Latin America

New Roles for an ancient organelle: Ciliary defects cause cystic kidney disease and structural birth defects

Non-coding RNA and polycystic kidney disease

Webinar: Update on slowing CKD progression (part 2 of series)

Webinar: Health Care Transition from Pediatric to Adult-focused Health Services: Lessons from the Field

Webinar: Desafíos para mejorar la atención de ERC en América Latina (SPANISH EDITION)

Kidney stones are common after bariatric surgery

Uremic pruritus

Prevention of CKD – How is it done in China

Health disparities in CKD: Why are African Americans at increased risk?

Nutritional Issues in CKD

Prevention: Always talked about but how is it done? (Perspective from a low-income country)

Bone Mineralization in CKD patients

Wnt and related signaling pathways in chronic renal fibrosis

Kidney Care in the UK

Endothelial Dysfunction in the Pathogenesis of Chronic Kidney Disease

Multidisciplinary care strategies in disadvantaged populations with CKD

Macrophages & Dendritic Cells: role in pathogenesis & therapy of kidney disease

CKDopps: Learning from practice variations in advanced CKD with early findings from Brazil

New Findings from CKD cohort studies from around the world: China

How well do equations for estimating GFR perform in different ethnic groups?

Risk factors for progression of CKD and disadvantaged populations

Towards cooperative actions against CKD in the Asian-Pacific region

Vascular calcification – the role of Klotho

CAN – PREDDICT (Canada)

CKD Classifications: Revisited

Clinical Practice Patterns for CKD-MBD in the Cinacalcet Era

Should we anticoagulate for atrial fibrillation in CKD/ESRD? (CON)

USE AND MISUSE OF TRADITIONAL ALTERNATIVE MEDICINE IN CHRONIC KIDNEY DISEASE PATIENTS: A CROSS-SECTIONAL STUDY

Chronic Allograft Injury

Current Therapy of Nephrotic Syndrome (MCD, Primary FGS, Primary MN)

MAKE YOUR DIAGNOSIS The Case | Idiopathic hypocomplementemic interstitial nephritis

Metformin and other antidiabetic agents in renal failure patients

Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1 (Commentary)

Should we anticoagulate for atrial fibrillation in CKD/ESRD? (PRO)

Management of pregnancy in CKD

Toward the podocyte protection therapy

Use of phosphate binders in CKD: Why, when which?

BP targets in CKD – are they necessary? (CON)

Anatomical and Physiological Changes in the Kidney with Aging

Evidence-based Clinical Practice Guideline for CKD 2013

Webinar:Dyslipidemia in CKD: Mechanisms, Consequences and Treatment Options by Stage

Evidence-based clinical practice guideline for CKD 2013 langjpn

Medullary Cystic Kidney Disease 1: A gene discovery odyssey

ROBO2 forms a protein complex with ILK and Loss of ROBO2 alleviates the glomerular phenotype of ILK podocyte-specific knockout mice audioicon

A mass spectrometry-based test for MCKD1 audioicon

Podocyte MDM2 prevents p53 overactivation-related cell death (podoptosis), proteinuria and glomerulosclerosis audioicon

Genetics of Congenital Urinary Tract Defects

Finding New Therapies for Genetic Syndromes: Chemical Suppressors of Disease Using the Zebrafish

The ciliopathy protein ANKS6 is the critical activator of NEK8 kinase, regulating situs determination, cardiopulmonary development and renal morphogenesis audioicon

Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy audioicon